More Than 235,000 Patients Supported with Impella® Heart Pumps
With today’s innovative technology, minimally invasive treatment options allow patients to recover the function of their native heart.
Patients and Caregivers
Protected PCI can be a safe treatment option to address severe coronary artery disease or advanced heart failure.
Health Care Professionals
Explore clinical data, educational opportunities and resources regarding the latest breakthroughs in cardiac and respiratory research.
Multi-Center, Multi-Society Study of Impella®-Supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%
September 20, 2022
Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81%
September 19, 2022